Pretreatment Tumor-infiltrating CD8 + T Cell Numbers Are Associated With the Response to Tremelimumab Plus Durvalumab in Hepatocellular Carcinoma
Year: 2026
Type: article
Study design: Observational Study
Source: Anticancer Research
Institutions: Aso Iizuka Hospital, Ichinomiyanishi Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7166586283
